0006-3029 : Keytruda 50 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution

Labeler: Merck Sharp & Dohme Corp.
Product Type: Human Prescription Drug
Drug Name:  Keytruda
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: BLA125514
Rev. Date: 

NDC Package Codes:

  • 0006-3029-02: 1 VIAL IN 1 CARTON (0006‑3029‑02) > 15 ML IN 1 VIAL (0006‑3029‑01)

Active Ingredients:

  • Pembrolizumab

Dosage Strength:

  • 50 mg/2mL

Pharmaceutical Classes:

  • Programmed Death Receptor-1 Blocking Antibody [EPC]
  • Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Related Products:

Based on records with the same trade name.
  • 0006-3026 Keytruda 25 mg/ml Intravenous Injection, Solution by Merck Sharp & Dohme Corp.


Scan the QR code below to easily reference this data in the future:

NDC 0006-3029 QR Code

< Prev: 0006-3026Next: 0006-3061 >

Related Discussions:

I just failed Ippy. Now my oncologist wants to start Keytruda 1/16/15. Those of you who have been on Keytruda for awhile... 4 replies
Thyroid cancer and KEYTRUDA
I have stage 4 thyroid cancer which has metastasized to my lungs. Although it is slow growing, the cancer will kill me. ... 28 replies
Pembrolizumab and Glutathione
My husband is in immunotherapy, undergoing 1 infusion of pembrolizumab ('Keytruda') every three weeks. Is it hel...

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 August 2015.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA